Contact Details

Professor Goodnow translates genomic DNA sequence analysis of the human immune system into understanding the cause of immune disorders and developing more effective, personalised treatments.

He has forged a close partnership between Garvan and Israel’s Weizmann Institute of Science, and has overseen the development of the multi-million dollar Garvan-Weizmann Centre for Cellular Genomics, the only multidisciplinary centre of its kind in the southern hemisphere. He was key to the development of CIRCA (Clinical Immunogenomics Research Consortium Australia), a Garvan-led national initiative that seeks to diagnose, understand and treat individuals with rare immune disorders through a combination of genomic DNA sequencing, clinical expertise and biomedical research.

Professor Goodnow is now leading Hope Research – a transformative research program that is an initiative of the Garvan-Weizmann partnership and is supported by The Bill and Patricia Ritchie Foundation. Hope Research aims to uncover a common cause for all autoimmune disease, which include more than 100 different diseases that collectively affect one in eight people. Using single cell DNA sequencing, Professor Goodnow and his team are tracking down and identifying the ‘rogue’ immune cells in the blood of adults with 44 autoimmune diseases, which drive the immune system to attack parts of the body.

Professor Chris Goodnow is the Executive Director of the Garvan Institute of Medical Research. He commenced his directorship in 2018.

Prof Goodnow holds The Bill and Patricia Ritchie Foundation Chair as Head of the Immunogenomics laboratory, a NHMRC Senior Principal Research Fellow, and is Professor and Director of the Cellular Genomics Futures Institute at UNSW Sydney.

See his full biography on the Garvan website.